Genomic Epidemiology and Public Health Applications
Module Sequence Completed!
You have processed all queries for this module. Excellent performance!
Explore other knowledge matrices or review your progress.
Social Sharing!
Share your knowledge:
Keep going! After this module, consider:
Professional Skills: Scientific Presentation and Reporting
Start Next ModuleSuggest Favorite subject or vote for a trending one!
Having trouble? Here are some quick links:
No study tools available yet.
Time on task: 0 mins
No helpful links available yet.
You have processed all queries for this module. Excellent performance!
Explore other knowledge matrices or review your progress.
For giardiasis in a patient with intolerance to metronidazole, several effective alternatives exist. Tinidazole is a nitroimidazole like metronidazole but is often better tolerated and can be given as a single dose (2g). However, cross-reactivity can occur. Nitazoxanide is a broad-spectrum antiprotozoal with a different mechanism and is well-tolerated, given as 500mg twice daily for 3 days. Paromomycin, a non-absorbable aminoglycoside, is another alternative, especially in pregnancy, but requires a longer course (10 days). Quinacrine is also effective but has more side effects. Among the options, Nitazoxanide is a widely accepted, well-tolerated, and effective first-line alternative. Albendazole (B) has activity but is not typically first-line for giardiasis monotherapy. Ciprofloxacin (C) is for bacteria, not Giardia. Ivermectin (D) is for helminths, not protozoa.
Break down complex topics into smaller, manageable chunks for easier recall.
Zambia